Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients

N/ANot Yet RecruitingNCT07057154

Assiut University97 enrolled

Overview

The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.

Primary (Main): determine the levels of the GHI And RDW In Critically Ill Patients at Critical and intermediate care units. b. Secondary (Subsidiary): Evaluate the prognostic significance of these parameters on patient outcomes, such as overall survival, progression-free survival, response to treatment.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Critical Ill Patients

Interventions

Hbg and RDWDEVICE

Hbg and RDW as prognstic indicator in critical ill patients

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis 2. diabtic Patients 3-animic Patients Exclusion Criteria: * Patients under 18 years of age * ICU stay \< 24 h * patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .

Outcomes

Primary Outcomes

Glycated Hemoglobin level

Measurement of Hb level in all patients upon ICU admission.

Time frame: Baseline

Red Cell Distribution Width (RDW)

Measurement of RDW in all patients upon ICU admission.

Time frame: baseline

Hemoglobin (Hb) Level

Measurement of Hb level in all patients upon ICU admission.

Time frame: baseline

Central Contacts

Rania Moukhter Aziz eldeam

CONTACT

+201022004702 Moukhterrania@gmail.com

Alaa ELdean Abd Elmoniem, Prof

CONTACT

+201112732730 alaaelmoniem@aun.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.